Impinj Set To Revolutionize Logistics With Tracking Chips. CEO Eyes 'Gigantic Opportunity.
Impinj, a maker of chips and systems for tracking assets, is just getting started in its growth trajectory, its CEO says.
PI - Impinj, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$178.83
DETAILS
HIGH:
$220.00
LOW:
$144.00
MEDIAN:
$175.50
CONSENSUS:
$178.83
UPSIDE:
8.03%
Stock News
Should You Buy Impinj (PI) After Golden Cross?
Impinj, Inc. (PI) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, PI's 50-day simple moving average broke out above its 200-day moving average; this is known as a "golden cross.
California State Teachers Retirement System Increases Position in Impinj, Inc. $PI
California State Teachers Retirement System increased its position in shares of Impinj, Inc. (NASDAQ: PI) by 29.3% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 33,902 shares of the company's stock after purchasing an additional 7,678 shares during the period.
Impinj, Inc. (PI) Q2 2026 Earnings Call Transcript
Impinj, Inc. (PI) Q2 2026 Earnings Call Transcript
Impinj Q2 Earnings Call Highlights
Impinj NASDAQ: PI reported record second-quarter revenue, adjusted EBITDA and earnings per share, supported by demand for its RAIN RFID Endpoint IC products across retail, supply chain and logistics markets. Management also projected strong sequential growth in the third quarter, citing bookings strength, an accelerating custom ASIC ramp and expected inventory rebuilding by inlay and label partners.
Impinj (PI) Tops Q2 Earnings and Revenue Estimates
Impinj (PI) came out with quarterly earnings of $0.86 per share, beating the Zacks Consensus Estimate of $0.81 per share. This compares to earnings of $0.8 per share a year ago.
Impinj Reports Second Quarter 2026 Financial Results
SEATTLE--(BUSINESS WIRE)--Impinj Reports Second Quarter 2026 Financial Results.
Impinj, Inc. $PI Shares Acquired by Fifth Third Bancorp
Fifth Third Bancorp grew its stake in Impinj, Inc. (NASDAQ: PI) by 4,821.8% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 8,564 shares of the company's stock after buying an additional 8,390 shares during the period. Fifth
What's going on with Seattle startup funding, a Kalshi setback, Impinj's long game, and a smartphone detox
This week on the GeekWire Podcast: Seattle startup funding fell about 40% in the first half of 2026 as AI reshaped the venture market — plus a Kalshi court setback, Impinj's 10 years on the Nasdaq, and could you go without your smartphone for five weeks?
The little chips that could: How Impinj has survived 26 years in a market that's ‘just getting going'
More than a quarter-century after Impinj was founded, CEO Chris Diorio and team rang the Nasdaq opening bell Tuesday to mark the Seattle RFID chipmaker's 10th anniversary as a public company.
Impinj to Announce Second-Quarter 2026 Financial Results
SEATTLE--(BUSINESS WIRE)--Impinj to Announce Second-Quarter 2026 Financial Results.
Director Sells 33,000 Impinj Shares Worth $4.6 Million
33,412 shares were sold indirectly on June 4, 2026, with an estimated transaction value of ~$4.57 million based on the reported price of $136.84 per share. This sale represented 3.63% of Sylebra Capital LLC's indirect holdings in Impinj, reducing total indirect ownership from 921,467 to 888,055 shares.
Director Sells 45,000 Impinj Shares Worth $6.4 Million
45,037 shares were indirectly sold for a total transaction value of ~$6.4 million, based on a weighted average price of $141.87 per share during June 2–3, 2026. The sale represented 4.66% of Sylebra Capital LLC's indirect holdings, reducing indirect ownership from 967,000 to 921,467 shares; direct holdings remained at zero.
Intel vs. Impinj: Which Technology Stock Is a Better Buy in 2026?
Intel is aggressively expanding its foundry business and AI accelerator offerings to diversify beyond traditional PC and data center chips. Impinj maintains a specialized lead in RAIN RFID technology, though its revenue remains highly concentrated among a small number of partners.
Insiders Are Selling These 3 Stocks—Should Investors Be Concerned?
Insider sales are hitting two massive stocks in industrials and retail, as well as a small-cap chip stock. Across these names, insiders are sending bearish signals, but their severity differs meaningfully.
New TALVEY® (talquetamab-tgvs) plus DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) data demonstrate the strength of a bispecific combination in earlier-line relapsed or refractory multiple myel
New TALVEYÂ (talquetamab-tgvs) plus DARZALEX FASPROÂ (daratumumab and hyaluronidase-fihj) data demonstrate the strength of a bispecific combi
Large Impinj Investor Trims Position by $11.3 Million
Impinj connects physical items to the digital world with advanced RFID solutions; a key insider recently reduced their indirect holdings.
Imagion Biosystems' IND Application for MagSense® Phase 2 Clinical Trial Clears FDA Review
[url="]Imagion Biosystems, Ltd. (ASX: IBX)[/url] has announced that the US Food and Drug Administration (FDA) completed its review of the company's investigati
Impinj (PI) Just Reclaimed the 200-Day Moving Average
After reaching an important support level, Impinj (PI) could be a good stock pick from a technical perspective. PI surpassed resistance at the 200-day moving average, suggesting a long-term bullish trend.
Impinj to Participate in Evercore Global TMT Conference
SEATTLE--(BUSINESS WIRE)--Impinj to Participate in Evercore Global TMT Conference.
Price Targets
Impinj initiated with an Outperform at BMO Capital
$220.00
(was $159.73)
Harsh Kumar
·
BMO Capital
Impinj Inc (PI) PT Lowered to $168 at Needham
$168.00
(was $139.30)
James Ricchiuti
·
Needham
Impinj price target raised to $190 from $175 at Jefferies
$190.00
(was $139.30)
Blayne Curtis
·
Jefferies
Impinj price target raised to $176 from $169 at Barclays
$176.00
(was $144.92)
Barclays
Impinj price target raised to $144 from $112 at Evercore ISI
$144.00
(was $142.28)
Mark Lipacis
·
Evercore ISI
Impinj price target raised to $175 from $155 at UBS
$175.00
(was $120.04)
UBS
Impinj price target lowered to $155 from $190 at UBS
$155.00
(was $153.83)
UBS
Impinj price target lowered to $200 from $255 at Susquehanna
$200.00
(was $110.92)
Christopher Rolland
·
Susquehanna
Impinj price target lowered to $175 from $255 at Needham
$175.00
(was $153.83)
Needham
Impinj price target lowered to $170 from $246 at Cantor Fitzgerald
$170.00
(was $153.83)
Troy Jensen
·
Cantor Fitzgerald
Impinj downgraded to In Line from Outperform at Evercore ISI
$112.00
(was $153.83)
Mark Lipacis
·
Evercore ISI
Impinj price target lowered to $175 from $211 at Barclays
$175.00
(was $153.83)
Barclays
Impinj price target lowered to $220 from $235 at Roth Capital
$220.00
(was $153.83)
Roth Capital
Impinj price target lowered to $190 from $200 at UBS
$190.00
(was $162.13)
UBS
Impinj price target raised to $211 from $200 at Barclays
$211.00
(was $175.55)
Barclays
Impinj price target raised to $255 from $235 at Susquehanna
$255.00
(was $218.80)
Susquehanna
Impinj price target raised to $255 from $195 at Needham
$255.00
(was $241.91)
James Ricchiuti
·
Needham
Impinj price target raised to $235 from $165 at Roth Capital
$235.00
(was $241.91)
Scott Searle
·
Roth Capital
Impinj price target raised to $230 from $180 at Piper Sandler
$230.00
(was $202.08)
Piper Sandler
Impinj price target raised to $235 from $180 at Susquehanna
$235.00
(was $200.72)
Susquehanna